Comorbidity defines asthmatic patients' risk of COVID-19 hospitalization: A global perspective.

ABSTRACT:

Background

The global epidemiology of asthma among patients with coronavirus disease 2019 (COVID-19) presents striking geographic differences, defining prevalence zones of high and low co-occurrence of asthma and COVID-19.

Objective

We aimed to compare asthma prevalence among hospitalized patients with COVID-19 in major global hubs across the world by applying common inclusion criteria and definitions.

Methods

We built a network of 6 academic hospitals in Stanford (Stanford University)/the United States; Frankfurt (Goethe University), Giessen (Justus Liebig University), and Marburg (Philipps University)/Germany; and Moscow (Clinical Hospital 52 in collaboration with Sechenov University)/Russia. We collected clinical and laboratory data for patients hospitalized due to

SUBMITTER: Skevaki C 

PROVIDER: S-EPMC9632231 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature